Commonwealth Equity Services’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
SCM
BGI
JT
OCA
PA
RCM
Commonwealth Equity Services's PALI Position: Q2 2026 in Review
Commonwealth Equity Services sold out of Palisade Bio (PALI) in Q2 2026, closing a stake of 16,500 shares — an estimated $28.9K sold.
Commonwealth Equity Services first reported a position in PALI in Q4 2025 and held it in 2 quarters. The position peaked at $39.1K in Q4 2025. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.
- Commonwealth Equity Services reported no remaining Palisade Bio position as of Q2 2026 after selling out during the quarter.
- Commonwealth Equity Services sold 16,500 Palisade Bio shares in Q2 2026, an estimated $28.9K.
- Commonwealth Equity Services first reported a position in Palisade Bio in Q4 2025 and held it in 2 quarters.
- Commonwealth Equity Services's Palisade Bio position peaked at $39.1K in Q4 2025.
- 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.